Clinical Report: Contrast Agent-Reduced Photon Counting Detector CT for TAVR
Overview
This study evaluates the diagnostic performance of a reduced contrast media dose (RCD) protocol using photon-counting detector CT (PCDCT) for transcatheter aortic valve replacement (TAVR) planning. Results indicate that RCD can maintain diagnostic quality while minimizing contrast agent volume, addressing safety concerns in patients with impaired renal function.
Background
Transcatheter aortic valve replacement (TAVR) is a critical intervention for patients with severe aortic valve stenosis, particularly among the elderly. Pre-procedural CT imaging is essential for accurate anatomical assessment and planning. However, the use of iodinated contrast media poses risks, especially in patients with renal impairment, necessitating strategies to reduce contrast volume without compromising diagnostic quality.
RCD protocol reduced contrast media volume from 80 mL to 52.5 mL.
Diagnostic quality was maintained in the RCD group despite lower contrast usage.
PCDCT demonstrated improved iodine sensitivity compared to conventional CT.
Patients with impaired renal function benefit from reduced contrast exposure.
Environmental and safety concerns regarding contrast media are addressed with RCD protocols.
Clinical Implications
The implementation of reduced contrast media protocols in TAVR planning can enhance patient safety, particularly for those with renal impairment. Clinicians should consider adopting photon-counting detector CT techniques to optimize imaging while minimizing the risks associated with iodinated contrast agents.
Conclusion
The study supports the use of reduced contrast media in PCDCT for TAVR planning, highlighting its potential to maintain diagnostic quality while addressing safety concerns. Further research may solidify these findings in broader clinical practice.
by Yannik C. Layer, Alexander Isaak, Narine Mesropyan, Patrick A. Kupczyk, Dmitrij Kravchenko, Marilia Voigt, Tatjana Dell, Julian A. Luetkens, Daniel Kuetting